Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Medicine.
Press releases published on July 24, 2025
Top Trend in the 2025 Partially Absorbable Mesh Market: Tech Innovations Enhancing Patient Recovery Outcomes
EIN Presswire
·
July 24, 2025
The Business Research Company's Top Trend in the 2025 Partially Absorbable Mesh Market: Tech Innovations Enhancing Patient Recovery Outcomes LONDON, GREATER LONDON, UNITED KINGDOM, July 24, 2025 /EINPresswire.com/ -- Save 30% On All Global Market …
An Open Letter from Cytogel Pharma CEO Dean Maglaris on the 'Vertex Effect' & Momentum for Innovation in Pain Management
EIN Presswire
·
July 24, 2025
DARIEN, CT, UNITED STATES, July 24, 2025 /EINPresswire.com/ -- Open Letter: We are encouraged by the growing momentum across the pain management landscape. Eli Lilly’s recent acquisition of SiteOne Therapeutics to expand its pain pipeline signals a clear …
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
GlobeNewswire
·
July 24, 2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer to filing its annual audited financial …
ACA Premiums Set to Spike—Health Sharing Offers a Smarter Solution
EIN Presswire
·
July 24, 2025
Health-Sharing Emerges as a Smarter Choice in the Wake of ACA Cost Spikes AUSTIN, TX, UNITED STATES, July 24, 2025 /EINPresswire.com/ -- A new analysis reveals that Affordable Care Act (ACA) marketplace insurers are planning the largest premium hikes …
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
GlobeNewswire
·
July 24, 2025
Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025 Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing annual growth of 48% SAN JOSE, Calif., July 24, 2025 (GLOBE …
Breaking Mental Health Care Barriers: Equilibrium MHS Offers Miami-Dade Integrated Treatment for Anxiety and Depression
EIN Presswire
·
July 24, 2025
Equilibrium Mental Health Services addresses critical mental health gaps with bilingual, culturally competent care for Miami's diverse communities MIAMI, FL, UNITED STATES, July 24, 2025 /EINPresswire.com/ -- Equilibrium Mental Health Services, a …
Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding
GlobeNewswire
·
July 24, 2025
Commack, NY, July 24, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers …
Algernon Announces Closing of the Private Placement Financing
GlobeNewswire
·
July 24, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), …
Rakovina Therapeutics Announces Warrant Exercise Incentive Program
GlobeNewswire
·
July 24, 2025
VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company” or “Rakovina”) a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug discovery is …
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
GlobeNewswire
·
July 24, 2025
TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased …
ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders
GlobeNewswire
·
July 24, 2025
Partial Adjournment for Proposal 2, Asset Sale Proposal, and Proposal 3, Charter Amendment Proposal; All Other Proposals Required for Merger Were Approved Stockholders are encouraged to vote FOR Proposals 2 and 3 by Calling 1-877-750-8310 (from the U.S. …
A Comprehensive Look at Paraffin Oil Market Size 2025 and Growth Forecast to 2031
EIN Presswire
·
July 24, 2025
The global paraffin oil market is projected to reach $3.3 billion by 2031, growing at a CAGR of 4.4% from 2022 to 2031. WILMINGTON, DE, UNITED STATES, July 24, 2025 /EINPresswire.com/ -- The global paraffin oil market was estimated at $2.2 billion in …
Survivor-Penned Companion Unbreakable Quietly Emerges as a Guiding Light for Readers in Need of Hope
EIN Presswire
·
July 24, 2025
SARASOTA, FL, UNITED STATES, July 24, 2025 /EINPresswire.com/ -- With over a dozen heartfelt reviews already in and more trickling in daily, Unbreakable is not just reaching readers—it’s staying with them. Written by Tamera Nielsen, a lifelong connector, …
CooperCompanies Announces Release Date for Third Quarter 2025
GlobeNewswire
·
July 24, 2025
SAN RAMON, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report third quarter 2025 financial results on Wednesday, August 27, 2025, at 4:15 PM ET. Following the release, …
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
GlobeNewswire
·
July 24, 2025
Southlake, TX, July 24, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart …
The Ensign Group Reports Second Quarter 2025 Results; Raises Annual Earnings and Revenue Guidance
GlobeNewswire
·
July 24, 2025
SAN JUAN CAPISTRANO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of companies, which provide post-acute healthcare services and invest in the long-term healthcare industry, …
Pharvaris Announces Closing of $201.2 Million Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
July 24, 2025
ZUG, Switzerland, July 24, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated …
Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta
GlobeNewswire
·
July 24, 2025
BELTSVILLE, Md., July 24, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced the …
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 24, 2025
CLEARWATER, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body …
Iovance Biotherapeutics to Host Second Quarter and First Half 2025 Financial Results and Corporate Updates Webcast on Thursday, August 7, 2025
GlobeNewswire
·
July 24, 2025
SAN CARLOS, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …